Kentucky Retirement Systems Has $5.91 Million Position in Colgate-Palmolive (NYSE:CL)

Kentucky Retirement Systems lessened its stake in Colgate-Palmolive (NYSE:CL) by 7.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 56,923 shares of the company’s stock after selling 4,902 shares during the period. Kentucky Retirement Systems’ holdings in Colgate-Palmolive were worth $5,909,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its stake in Colgate-Palmolive by 22.5% during the third quarter. Empowered Funds LLC now owns 69,602 shares of the company’s stock worth $7,225,000 after buying an additional 12,797 shares in the last quarter. Empirical Finance LLC boosted its position in shares of Colgate-Palmolive by 2.2% during the 3rd quarter. Empirical Finance LLC now owns 28,845 shares of the company’s stock valued at $2,994,000 after acquiring an additional 632 shares in the last quarter. Balboa Wealth Partners bought a new stake in Colgate-Palmolive in the third quarter valued at about $226,000. OneDigital Investment Advisors LLC raised its position in Colgate-Palmolive by 23.8% in the third quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company’s stock worth $1,539,000 after purchasing an additional 2,847 shares in the last quarter. Finally, Metis Global Partners LLC lifted its stake in Colgate-Palmolive by 13.1% during the third quarter. Metis Global Partners LLC now owns 28,671 shares of the company’s stock worth $2,976,000 after purchasing an additional 3,320 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Trading Up 2.3 %

Shares of NYSE CL opened at $93.56 on Friday. The company’s 50 day simple moving average is $99.31 and its 200 day simple moving average is $98.49. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The firm has a market capitalization of $76.44 billion, a P/E ratio of 26.81, a P/E/G ratio of 3.25 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CL. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective for the company. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Barclays increased their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.